Skip to main navigation Skip to search Skip to main content

Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)

  • Henrik Maagensen
  • , Sofie Hædersdal
  • , Jesper Krogh
  • , Torben Hansen
  • , Filip Krag Knop
  • , Anne Cathrine Baun Thuesen
  • , Tina Vilsbøll*
  • *Corresponding author for this work

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
Article numbere15387
JournalDiabetic medicine : a journal of the British Diabetic Association
Volume41
Issue number10
Early online date14 Jun 2024
DOIs
Publication statusPublished - Oct 2024

Cite this